
Gou qi zi, Goji, wolfberry, lycium fruit, bastard jasmine, box thorn, tea tree, matrimony vine
The berries of Lycium barbarum are used in traditional medicine to treat inflammation, skin irritation, nose bleeds, aches, pains and as sedatives (1). Lycium is also commonly used with other botanicals in Chinese medicine for poor vision, anemia, and cough (9). A polysaccharide isolated from lycium was shown to have antitumor (2) (10), immune enhancing (3), hepatoprotective (6) and neuroprotective (11) properties in vitro. It also showed radiosensitizing (4) and photoprotective (12) effects in mice.
In addition, lycium inhibited growth of ER positive breast cancer cells (13).
Small studies of lycium reported subjective improvement in well-being in healthy subjects (14) (15) (16), and its protective effects on macula in elderly subjects by preventing hypopigmentation (19).
Data from an observational study done in China suggest that polysacchardies from Lycium barbarum have positive effects when used with certain cancer treatments (5). It is unclear if similar effects can be observed with cancer treatments that are currently in use. In another study lycium was shown to reduce cardiotoxicity associated with doxorubicin (17). Well designed clinical trials are needed to determine Lycium’s anticancer potential.
Lycium may have an additive anticoagulant effect when used with warfarin (8) (18).
Despite many marketing claims of cancer preventive potential, the efficacy and safety of lycium products for cancer treatment in humans have not been established.
The bark and the berry contain betasitosterol which can prevent cholesterol absorption in the gastrointestinal tract (7). A cerebroside extracted from Lycium chinense was shown to block the release of glutamic pyruvic transaminase and sorbitol dehydrogenase, suggesting hepatoprotective activity (6).
Lycium barbarum polysaccharide (LBP) inhibits the growth of leukemia HL-60 cells (2) and increases expression of interleukin-2 and tumor necrosis factor alpha (3).
Lycium and related products have not been studied in large well-designed clinical trials.
Research cited in this monograph was not conducted at the Memorial Sloan-Kettering Cancer Center.
Amagase H, Sun B, Nance DM. Immunomodulatory effects of a standardized Lycium barbarum fruit juice in Chinese older healthy human subjects. J Med Food. 2009 Oct;12(5):1159-65.
Sixty healthy adults, aged 55-72 years, were randomized to receive Lycium barbarum fruit juice (120 mL/day) or placebo for 30 days. Individuals who took lycium juice showed a significant increase in immunological responses and subjective well-being compared to those in the placebo group. Adverse reactions were not reported.
Whether lycium products would produce similar effects in people with specific disorders is not known. Further research is warranted.
Cao GW, Yang WG, Du P. [Observation of the effects of LAK/IL-2 therapy combining with Lycium barbarum polysaccharides in the treatment of 75 cancer patients]. Zhonghua Zhong.Liu Za Zhi. 1994;16:428-31.
This is an observational study done in China on patients with a variety of cancers. The patients were treated with either LAK/IL-2 or a combination of LAK/IL-2 and Lycium Barbarum polysaccharides (LBP). The response rate, as judged by the objective regression of cancer, was 40.9% in patients who received the LBP compared to 16.1% in those treated with LAK/IL-2 alone. Patients who received the LBP supplement also had a greater increase in NK and LAK cell activities. However, it is unclear if lycium would show similar effects when used with other chemotherapy regimens. Further large scale studies are warranted.
Bottom Line: The safety efficacy of lycium products for cancer prevention and treatment in humans have not been established.
The berries of Lycium barbarum are used in traditional medicine to treat inflammation, skin irritation, nose bleeds, aches, pains and as sedatives. Lycium is also commonly used with other botanicals in Chinese medicine for poor vision, anemia, and cough. Polysaccharides isolated from the plant have been shown to improve immune response, improve the effects of radiation therapy, and inhibit growth of some cancer cells in laboratory and animal studies. An observational study conducted in China showed that lycium may improve the effects of certain therapy in humans. However, more well-designed studies are needed.
Sixty healthy adults, aged 55-72 years, were randomized to receive Lycium barbarum fruit juice (120 mL/day) or placebo for 30 days. Subjects who took lycium juice showed a significant increase in immunological responses and sbujective well-being compared to those in the placebo group. Adverse reactions were not reported.
Whether lycium products would produce similar effects in individuals with specific disorders is not known. Further research is warranted.
In a study conducted in China to determine if lycium could help improve the effects of other therapies, 75 patients with a variety of cancers were given either a regimen LAK/IL-2, or the LAK/IL-2 regimen along with an extract of lycium. Patients who received the LAK/IL-2 with the lycium extract had improved immune system activity. However, this effect has yet to be confirmed in well-designed clinical trials.
You are taking warfarin or other anticoagulants (Two cases of elevated INR were reported in patients on anticoagulant therapy following consumption of concentrated Chinese herbal tea made from lycium.)
None reported.
There have been reports of marketers misrepresenting the position of Memorial Sloan-Kettering Cancer Center on lycium products.
1. This Center has not conducted any clinical research on lycium products.
2. The products were not given or prescribed to our patients.